logo
Select company
Select metric
$ -79.29MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
9
Sector
23
Industry
17
History
41
$ 9.13Close
$ 3 - $ 10.28 52-Week Range
Ticker Information

Ticker

PSNL

Company Name

PERSONALIS INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

PERSONALIS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PSNL - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 11.93M$ -91.22M$ -79.29M
3/31/2025$ 12.15M$ -84M$ -71.85M
12/31/2024$ 12.34M$ -81.24M$ -68.9M
9/30/2024$ 11.52M$ -91.39M$ -79.87M
6/30/2024$ 12.73M$ -81.37M$ -68.64M
3/31/2024$ 13.01M$ -92.46M$ -79.45M
12/31/2023$ 13.15M$ -108.1M$ -94.95M
9/30/2023$ 14.86M$ -112.55M$ -97.69M
6/30/2023$ 13.59M$ -109.93M$ -96.34M
3/31/2023$ 12.33M$ -113.53M$ -101.2M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PERSONALIS INC's latest trailing twelve months (TTM) EBITDA stands at $ -27.54M.
  • Over the past 5 years, PERSONALIS INC's average EBITDA has been $ -71.42M.
  • The median EBITDA for PERSONALIS INC during this period was $ -75.57M
  • PERSONALIS INC reached its highest EBITDA over the past 5 years at $ -27.54M.
  • The lowest EBITDA recorded by PERSONALIS INC in the same timeframe $ -101.2M

PERSONALIS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
KURA : KURA ONCOLOGY INC $ -192.46MCBLL : CERIBELL INC $ -46.14MSTIM : NEURONETICS INC $ -38.66MNKTR : NEKTAR THERAPEUTICS $ -94.15MSAGE : SAGE THERAPEUTICS INC $ -300.6MTBPH : THERAVANCE BIOPHARMA INC $ 48.42MYMAB : Y-MABS THERAPEUTICS INC $ -26.3MXGN : EXAGEN INC $ -11.47MBDSX : BIODESIX INC $ -27.69MADCT : ADC THERAPEUTICS SA $ -115.26M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for PERSONALIS INC is calculated as follows: EBIT [ $ -34.54M ] + DepAmor [ $ 7M ]
(=) EBITDA [ $ -27.54M ]

PSNL - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -101.2M

Minimum

Mar 31, 2023

$ -27.54M

Maximum

Sep 30, 2020

$ -71.42M

Average

$ -75.57M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.79M with a standard deviation of $ 166.94M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.79M
median$ 8.83M
std$ 166.94M